ArticleTherapeutic innovation & regulatory science2026
Risk of Venous Thromboembolism with Pemafibrate in Dyslipidemia: A Nationwide, Retrospective, Cohort Study Using a Japanese Claims Database.
Kenichiro Ikeda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.